UK markets open in 5 hours 39 minutes
NIKKEI 225
38,303.90 +751.74 (+2.00%) HANG SENG
16,828.93 +317.24 (+1.92%) CRUDE OIL
83.32 -0.04 (-0.05%) GOLD FUTURES
2,333.30 -8.80 (-0.38%) DOW
38,503.69 +263.71 (+0.69%) Bitcoin GBP
53,550.46 -300.07 (-0.56%)
Eli Lilly and Company (LLY)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 695.32B |
| Enterprise value | 717.62B |
| Trailing P/E | 126.09 |
| Forward P/E | 58.48 |
| PEG ratio (5-yr expected) | 1.39 |
| Price/sales (ttm) | 19.36 |
| Price/book (mrq) | 64.55 |
| Enterprise value/revenue | 21.03 |
| Enterprise value/EBITDA | 83.76 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.37 |
| 52-week change 3 | 90.03% |
| S&P500 52-week change 3 | 23.06% |
| 52-week high 3 | 800.78 |
| 52-week low 3 | 370.68 |
| 50-day moving average 3 | 762.17 |
| 200-day moving average 3 | 616.85 |
Share statistics
| Avg vol (3-month) 3 | 3.07M |
| Avg vol (10-day) 3 | 2.38M |
| Shares outstanding 5 | 950.77M |
| Implied shares outstanding 6 | 950.77M |
| Float 8 | 897.84M |
| % held by insiders 1 | 0.16% |
| % held by institutions 1 | 84.35% |
| Shares short (28 Mar 2024) 4 | 5.42M |
| Short ratio (28 Mar 2024) 4 | 1.82 |
| Short % of float (28 Mar 2024) 4 | 0.64% |
| Short % of shares outstanding (28 Mar 2024) 4 | 0.57% |
| Shares short (prior month 29 Feb 2024) 4 | 5.42M |
Dividends & splits
| Forward annual dividend rate 4 | 5.2 |
| Forward annual dividend yield 4 | 0.71% |
| Trailing annual dividend rate 3 | 4.52 |
| Trailing annual dividend yield 3 | 0.62% |
| 5-year average dividend yield 4 | 1.45 |
| Payout ratio 4 | 77.93% |
| Dividend date 3 | 08 Mar 2024 |
| Ex-dividend date 4 | 14 Feb 2024 |
| Last split factor 2 | 2:1 |
| Last split date 3 | 16 Oct 1997 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 15.36% |
| Operating margin (ttm) | 34.14% |
Management effectiveness
| Return on assets (ttm) | 11.88% |
| Return on equity (ttm) | 48.44% |
Income statement
| Revenue (ttm) | 34.12B |
| Revenue per share (ttm) | 37.91 |
| Quarterly revenue growth (yoy) | 28.10% |
| Gross profit (ttm) | N/A |
| EBITDA | 12.31B |
| Net income avi to common (ttm) | 5.24B |
| Diluted EPS (ttm) | 5.78 |
| Quarterly earnings growth (yoy) | 13.00% |
Balance sheet
| Total cash (mrq) | 3.04B |
| Total cash per share (mrq) | 3.38 |
| Total debt (mrq) | 26.47B |
| Total debt/equity (mrq) | 243.63% |
| Current ratio (mrq) | 0.94 |
| Book value per share (mrq) | 11.98 |
Cash flow statement
| Operating cash flow (ttm) | 4.24B |
| Levered free cash flow (ttm) | 236.88M |
© 2024 Yahoo. All rights reserved.